Department of Orthopedic Surgery, Faculty of Medicine, University Malaya, Kuala Lumpur 50603, Malaysia.
Department of Physiology, Faculty of Medicine, University Malaya, Kuala Lumpur 50603, Malaysia.
Mar Drugs. 2023 May 17;21(5):304. doi: 10.3390/md21050304.
Tissue engineering and regenerative medicine (TERM) holds great promise for addressing the growing need for innovative therapies to treat disease conditions. To achieve this, TERM relies on various strategies and techniques. The most prominent strategy is the development of a scaffold. Polyvinyl alcohol-chitosan (PVA-CS) scaffold emerged as a promising material in this field due to its biocompatibility, versatility, and ability to support cell growth and tissue regeneration. Preclinical studies showed that the PVA-CS scaffold can be fabricated and tailored to fit the specific needs of different tissues and organs. Additionally, PVA-CS can be combined with other materials and technologies to enhance its regenerative capabilities. Furthermore, PVA-CS represents a promising therapeutic solution for developing new and innovative TERM therapies. Therefore, in this review, we summarized the potential role and functions of PVA-CS in TERM applications.
组织工程与再生医学(TERM)在满足创新性疾病治疗方法的日益增长的需求方面具有巨大的潜力。为了实现这一目标,TERM 依赖于各种策略和技术。最突出的策略是开发支架。聚乙烯醇-壳聚糖(PVA-CS)支架因其生物相容性、多功能性以及支持细胞生长和组织再生的能力,成为该领域很有前途的材料。临床前研究表明,PVA-CS 支架可以被制造并定制,以满足不同组织和器官的特定需求。此外,PVA-CS 可以与其他材料和技术结合使用,以增强其再生能力。此外,PVA-CS 为开发新的和创新的 TERM 治疗方法提供了有前途的治疗解决方案。因此,在这篇综述中,我们总结了 PVA-CS 在 TERM 应用中的潜在作用和功能。
Mater Sci Eng C Mater Biol Appl. 2019-10-23
Zhonghua Shao Shang Za Zhi. 2011-8
Macromol Biosci. 2021-4
Sichuan Da Xue Xue Bao Yi Xue Ban. 2007-7
Bioact Mater. 2025-2-22
Beilstein J Nanotechnol. 2025-2-26
Materials (Basel). 2024-1-18
Molecules. 2023-2-15
Polymers (Basel). 2022-12-20
Tissue Eng Part C Methods. 2022-10
Pharmaceutics. 2022-7-7
Front Med (Lausanne). 2022-1-28
ACS Appl Bio Mater. 2019-12-16